CoChat

Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T‐Lymphocytes

MATTERN, T., SCHOLZ, W., FELLER, A. C., FLAD, H.‐D., ULMER, A. J. · 1991 · Scandinavian Journal of Immunology
Cited by 76

The DOI matches its Crossref record.

Abstract

CD26 is an activation antigen which is expressed on the surface of human T‐lymphocytes. It has been characterized to be the dipeptidyl peptidase IV (DPP IV). Considerable amounts of CD26 are already present on resting T‐lymphocytes. The expression of CD26 is enhanced by T‐cell milogens or antigens. A correlation of CD26 expression and of enhanced enzymatic activity was observed after T‐cell activation. Our data indicate that not only the immunoreactivity, but also the enzymatic activity of CD26 are detectable on the cell surface. In addition, de novo expression of CD26 was demonstrated on CD26‐negative T‐cells after mitogenic or antigenic stimulation. CD26 expression is initiated during the G 1 phase of the cell cycle. The expression occurs nearly simultaneously with HLA‐DR, but later than CD25. Similar lo CD25 and HLA‐DR, CD26 is not a permanent marker on the surface of T‐lymphocytes, but is down‐regulated after 7 days of culture. When testing the influence of interleukin I, interleukin 2, tumour necrosis factor, and interferon‐γ on the expression of CD26, no effect was found on unstimulated or on mitogen‐stimulated T‐lymphocytes. The binding of two different monoclonal antibodies against CD26 (anti‐DPP IV and anti‐Tal) to resting and activated T‐lymphocytes revealed a different pattern of immunoreactivity. Resting T‐lymphocytes reacted stronger with anti‐DPP IV than with anti‐Ta I. However, binding of the two monoclonal antibodies to T‐cell blasts did not show significant differences. These data indicate that CD26 may be expressed in differently modulated configurations on the surface of T‐cells, which may be associated with a distinct status of activation and or function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-3083.1991.tb02548.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 76

Metadata

Authors
MATTERN, T., SCHOLZ, W., FELLER, A. C., FLAD, H. ‐., & ULMER, A. J.
Venue
Scandinavian Journal of Immunology
Publisher
Wiley
Published
1991-06
Volume
33
Issue
6
Pages
737-748
ISSN
  • 0300-9475 (ISSN-L)
  • 1365-3083
OpenAlex
W1992447913
Cited by
76
References
0
FWCI
2.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T‐Lymphocytes. https://app.cochat.ai/papers/10.1111/j.1365-3083.1991.tb02548.x
The paper
MATTERN, T., SCHOLZ, W., FELLER, A. C., FLAD, H. ‐., & ULMER, A. J. (1991). Expression of CD26 (Dipeptidyl Peptidase IV) on Resting and Activated Human T‐Lymphocytes. Scandinavian Journal of Immunology. https://doi.org/10.1111/j.1365-3083.1991.tb02548.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.